Continuous treatment with FTS confers resistance to apoptosis and affects autophagy

Eran Schmukler(Tel Aviv University), Ronit Pinkas‐Kramarski(Tel Aviv University)

PLoS ONE

February 2, 2017

10.1371/journal.pone.0171351

Cited by 4

Related Papers

Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer

|Cell Death and Disease|2018|43

Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer

|Oncotarget|2016|38

Nucleolin inhibitor GroA triggers reduction in epidermal growth factor receptor activation: Pharmacological implication for glial scarring after spinal cord injury

|Journal of Neurochemistry|2016|10